tadalafil has been researched along with Muscle Contraction in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuta, F; Hashimoto, K; Ichihara, K; Kobayashi, K; Masumori, N; Shinkai, N; Tabata, H; Tanaka, T | 1 |
| Egawa, S; Furuta, A; Igarashi, T; Koike, Y; Suzuki, Y; Yoshimura, N | 1 |
| Fonteles, MC; Gonzaga-Silva, LF; Linhares, BL; Marinho, LB; Moraes, MO; Nascimento, NRF; Reges, R; Santos, CF; Silva, APG | 1 |
| Fujimura, M; Fukui, T; Oka, M; Oyama, T; Yoshifuji, M; Yoshinaga, R | 1 |
| Fujimoto, K; Gotoh, D; Hirayama, A; Hori, S; Iwamoto, T; Iwasaki, H; Miyake, M; Morizawa, Y; Nishi, E; Tanaka, N; Torimoto, K | 1 |
| Erdem, SR; Keskin, U; Peskircioglu, CL; Toksoz, S | 1 |
| Carini, M; Cellai, I; Comeglio, P; Filippi, S; Gacci, M; Maggi, M; Maneschi, E; Morelli, A; Sarchielli, E; Vannelli, GB; Vignozzi, L | 1 |
| Benigni, F; Briganti, A; Buono, R; Castiglione, F; Freschi, M; Hedlund, P; La Croce, G; Montorsi, F; Moschini, M; Villa, L | 1 |
| Fuchikami, C; Kawai, Y; Oka, M; Oyama, T; Yoshinaga, R | 1 |
| Antunes, E; Priviero, FB; Teixeira, CE; Toque, HA; Webb, RC; Zemse, SM | 1 |
| Allona, A; Angulo, J; Cuevas, P; Fernández, A; La Fuente, JM; Moncada, I; Sáenz de Tejada, I | 1 |
| Antunes, E; Baracat, JS; Claudino, MA; De Nucci, G; Priviero, FB; Teixeira, CE; Webb, RC | 1 |
| Becker, AJ; Gratzke, C; Kedia, G; Reich, O; Schlenker, B; Seitz, M; Stief, CG; Uckert, S | 1 |
| Asai, A; Kaneki, M; Martyn, JA; Ouchi, Y; Sahani, N; Yasuhara, SE | 1 |
14 other study(ies) available for tadalafil and Muscle Contraction
| Article | Year |
|---|---|
Long-term tadalafil administration can prevent functional and structural changes of the urinary bladder in male rats with partial bladder outlet obstruction.
Topics: Animals; Male; Muscle Contraction; Muscle, Smooth; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Tadalafil; Urethra; Urinary Bladder; Urinary Bladder Neck Obstruction; Urological Agents | 2020 |
Effects of combined treatment of tadalafil and tamsulosin on bladder dysfunction via the inhibition of afferent nerve activities in a rat model of bladder outlet obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Blood Pressure; Drug Therapy, Combination; Female; Muscle Contraction; Muscle, Smooth; Phosphodiesterase 5 Inhibitors; Rats; Sulfonamides; Tadalafil; Tamsulosin; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2018 |
Effect of co-administration of two different phosphodiesterase inhibitors and a β
Topics: Adrenergic beta-3 Receptor Agonists; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Ethanolamines; Humans; Male; Mice; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Rolipram; Tadalafil; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive | 2018 |
Comparison of the Effects of Tadalafil and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Electric Stimulation; Indoles; Male; Muscle Contraction; Naphthalenes; Phosphodiesterase 5 Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Seminal Vesicles; Tadalafil; Tamsulosin; Vas Deferens | 2019 |
Tadalafil, a phosphodiesterase type 5 inhibitor, restores urethra and detrusor function in the initial phase of diabetes in rats.
Topics: Animals; Carbachol; Diabetes Mellitus, Experimental; Electric Stimulation; Female; Muscle Contraction; Muscle, Smooth; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Tadalafil; Urethra; Urinary Bladder | 2019 |
The effect of long-term oral tadalafil treatment on corpus cavernosum function in an experimental spinal cord transection rat model.
Topics: Acetylcholine; Animals; Arginine; Carbolines; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Erectile Dysfunction; In Vitro Techniques; Isometric Contraction; Male; Muscle Contraction; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penis; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Spinal Cord Injuries; Tadalafil; Vasodilator Agents | 2013 |
Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model.
Topics: Amides; Animals; Carbolines; Diet, High-Fat; Enzyme Inhibitors; Male; Metabolic Syndrome; Muscle Contraction; Muscle, Smooth; Pyridines; Rabbits; rho-Associated Kinases; Signal Transduction; Tadalafil; Up-Regulation; Urinary Bladder Diseases; Urological Agents | 2014 |
Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Animals; Carbolines; Drug Synergism; Electric Stimulation; Erectile Dysfunction; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Muscle Contraction; Phenylephrine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Tadalafil | 2014 |
Effects of the phosphodiesterase 5 inhibitor Tadalafil on bladder function in a rat model of partial bladder outlet obstruction.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Female; Muscle Contraction; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Tadalafil; Urinary Bladder; Urinary Bladder Neck Obstruction; Urination | 2016 |
Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
Topics: Animals; Carbolines; Drug Evaluation, Preclinical; Enzyme Inhibitors; Guanylate Cyclase; Imidazoles; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitroglycerin; Oxadiazoles; Penile Erection; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Quinoxalines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2009 |
Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.
Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Electric Stimulation; Humans; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase 5 Inhibitors; Prostate; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Urinary Bladder | 2012 |
Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: interaction with nitric oxide.
Topics: Animals; Carbachol; Carbolines; Colforsin; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; Oxadiazoles; Pyrazoles; Pyridines; Quinoxalines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Tadalafil; Tetrodotoxin | 2006 |
In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Butylscopolammonium Bromide; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Muscarinic Antagonists; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Piperazines; Potassium Chloride; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Ureter; Vardenafil Dihydrochloride | 2007 |
Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy.
Topics: Animals; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Hydrogen Peroxide; Ischemia; Mice; Mice, Transgenic; Muscle Contraction; Muscular Dystrophy, Animal; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil | 2007 |